Covestor’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Covestor's RCUS Position: Q3 2026 in Review
Covestor reduced its Arcus Biosciences (RCUS) stake by 40% in Q3 2026, selling an estimated $282 and leaving 15 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2745.
Covestor first reported a position in RCUS in Q4 2021 and has held it in 20 quarters since. The position peaked at $2K in Q2 2025. 47 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Covestor held 15 shares of Arcus Biosciences worth $0 as of Q3 2026.
- Covestor sold 10 Arcus Biosciences shares in Q3 2026, an estimated $282.
- Arcus Biosciences made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2745 holding.
- Covestor first reported a position in Arcus Biosciences in Q4 2021 and has held it in 20 quarters since.
- Covestor's Arcus Biosciences position peaked at $2K in Q2 2025.
- 47 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.